Why wait? Embark on a restoration relationship by calling Toll Free 1-888-691-1482 N0W
Since 1993, the Most Experienced out-patient Hyperbaric Centers with the Most Experienced Physicians.
Invasive fungus is common with little leukemia patient and compromised
immune system adults.
The Children’s Hospital primary oncologist for Carson wrote “he has had a miraculous recovery with hyperbaric oxygen contributing to this response. This infection is usually fatal, yet Carson has survived and at present remains on chemotherapy.”
Carson's health insurance PacifiCare has agreed that Carson should continue with HBOT treatments throughout 2007 to ensure that the virulent fungus mucor does not return. He continues with his chemotherapy at Childrens' Hospital, San Diego and regular HBOT sessions at our San Diego Center.
To learn about the touch'n'go saving of Carson, the cooperation of Children's hospital specialist physicians and surgeons, and the clinical details of his HBOT treatments. For the clinical details of how he was treated and why HBOT kills fungus, click here
PS September 2007. During a recent grand-rounds review at S.D. Children's Hospital, Carson's progress was reviewed. It was noted that he was the only little patient that has none of the usual sequels to his maintenance chemotherapy. Unlike the other little patients, Carson's hair is growing thick and strong, he has no aches or pains and is full of bouncing vitality. In essence, a "normal" little boy. The question was raised "What is Carson doing that these other children are not doing?" The answer was "three HBOT sessions each week!"
While Carson's HBOT Rx is to prevent the return of the fungus, the fact that his progress is greater than other little patients begs an answer to the question "should HBOT be a standard an adjunctive therapy for leukemia and lymphoma patients?" The answer could well lie in the fact that stem cells from bone marrow transplants are a common survival approach but hard to find -- "As many as 16,000 leukemia patients require a bone marrow transplant but have no matched relative or can't find a match in the national bone marrow registry -- Mary J Laughlin, M.D. Comprehensive Cancer Center and University Hospital of Cleveland Ireland Cancer Center. November 30 -2004
CARSON IS PRODUCING HIS OWN HEALTHY STEM CELLS ! ! !
Stem cells exist in the bone marrow of human beings and animals and are capable of changing their nature to become part of many different organs and tissues. In response to injury, these cells move from the bone marrow to the injured sites, where they differentiate into cells that assist in the healing process. The movement, or mobilization, of stem cells can be triggered by a variety of stimuli -- including pharmaceutical agents and hyperbaric oxygen treatments. Where as drugs are associated with a host of side effects, hyperbaric oxygen treatments carry a significantly lower risk of such effects. "This is the safest way clinically to increase stem cell circulation, far safer than any of the pharmaceutical options," said Stephen Thom, MD, Ph.D., Professor of Emergency Medicine at the University of Pennsylvania School of Medicine and lead author of the study. "This study provides information on the fundamental mechanisms for hyperbaric oxygen and offers a new theoretical therapeutic option for mobilizing stem cells." "We reproduced the observations from humans in animals in order to identify the mechanism for the hyperbaric oxygen effect," added Thom. "We found that hyperbaric oxygen mobilizes stem/progenitor cells because it increases synthesis of a molecule called nitric oxide in the bone marrow. This synthesis is thought to trigger enzymes that mediate stem/progenitor cell release."
|